These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38825092)

  • 21. Endocrine disrupting chemicals in the atmosphere: Their effects on humans and wildlife.
    Annamalai J; Namasivayam V
    Environ Int; 2015 Mar; 76():78-97. PubMed ID: 25569353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer risk in relation to occupations with exposure to carcinogens and endocrine disruptors: a Canadian case-control study.
    Brophy JT; Keith MM; Watterson A; Park R; Gilbertson M; Maticka-Tyndale E; Beck M; Abu-Zahra H; Schneider K; Reinhartz A; Dematteo R; Luginaah I
    Environ Health; 2012 Nov; 11():87. PubMed ID: 23164221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine-disrupting chemicals and endocrine neoplasia: A forty-year systematic review.
    Macedo S; Teixeira E; Gaspar TB; Boaventura P; Soares MA; Miranda-Alves L; Soares P
    Environ Res; 2023 Feb; 218():114869. PubMed ID: 36460069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A restatement of the natural science evidence base on the effects of endocrine disrupting chemicals on wildlife.
    Godfray HCJ; Stephens AEA; Jepson PD; Jobling S; Johnson AC; Matthiessen P; Sumpter JP; Tyler CR; McLean AR
    Proc Biol Sci; 2019 Feb; 286(1897):20182416. PubMed ID: 30963852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of and Challenges in Regulating Endocrine Disruptors - How Regulators and Industry Can Conquer?
    Dhiman SK; Dureja H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1664-1681. PubMed ID: 32504507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: Where exposomics meets metabolomics.
    Sun J; Fang R; Wang H; Xu DX; Yang J; Huang X; Cozzolino D; Fang M; Huang Y
    Environ Int; 2022 Jan; 158():106941. PubMed ID: 34689039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of Endocrine disrupting chemicals on myocardial fibrosis and related mechanism].
    Guo M; Xu J; Yu J
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Feb; 40(2):156-160. PubMed ID: 35255588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union.
    Beronius A; Rudén C; Hanberg A; Håkansson H
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):111-22. PubMed ID: 19500631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The environmental burden on endocrine neoplasia: a review on the documented impact of endocrine disrupting chemicals.
    Mangion J; Gruppetta M
    Expert Rev Endocrinol Metab; 2023; 18(6):513-524. PubMed ID: 37840278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
    Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
    Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the risk of exposures to endocrine disrupting chemicals.
    Munn S; Heindel J
    Chemosphere; 2013 Oct; 93(6):845-6. PubMed ID: 23911261
    [No Abstract]   [Full Text] [Related]  

  • 36. Environmental endocrine disruptors: Effects on the human male reproductive system.
    Sweeney MF; Hasan N; Soto AM; Sonnenschein C
    Rev Endocr Metab Disord; 2015 Dec; 16(4):341-57. PubMed ID: 26847433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine disrupting chemicals as potential risk factor for estrogen-dependent cancers.
    Rutkowska AZ; Szybiak A; Serkies K; Rachoń D
    Pol Arch Med Wewn; 2016 Aug; 126(7-8):562-70. PubMed ID: 27509913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure to endocrine-disrupting chemicals and implications for neurodevelopment.
    Özel F; Rüegg J
    Dev Med Child Neurol; 2023 Aug; 65(8):1005-1011. PubMed ID: 36808586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet: A Source of Endocrine Disruptors.
    Rashid H; Alqahtani SS; Alshahrani S
    Endocr Metab Immune Disord Drug Targets; 2020; 20(5):633-645. PubMed ID: 31642798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environmental Exposure to Non-Persistent Endocrine Disrupting Chemicals and Endometriosis: A Systematic Review.
    Wieczorek K; Szczęsna D; Jurewicz J
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.